NeoGenomics, Inc. - Common Stock (NQ:NEO)

7.790 +0.040 (+0.52%)

Streaming Delayed Price Updated: 11:05 AM EDT, Apr 2, 2026 Add to My Watchlist

Price and Volume

Volume	560,564
Open	7.680
Bid (Size)	7.770 (300)
Ask (Size)	7.800 (100)
Prev. Close	7.750
Today's Range	7.240 - 7.985
52wk Range	4.720 - 13.74
Shares Outstanding	122,816,314
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

3 of Wall Street’s Favorite Stocks We Think Twice About

Today 0:36 EDT

Wall Street is overwhelmingly bullish on the stocks in this article, with price targets suggesting significant upside potential. However, it’s worth remember...

Via StockStory

2 High-Flying Stocks to Consider Right Now and 1 That Underwhelm

March 23, 2026

"You get what you pay for" often applies to expensive stocks with best-in-class business models and execution. While their quality can sometimes justify the ...

Via StockStory

Performance

YTD	-33.8%	-33.8%
1 Month	-18.0%	-18.0%
3 Month	-33.8%	-33.8%
6 Month	-10.6%	-10.6%
1 Year	-16.7%	-16.7%

More News

NeoGenomics, Natera, and Amphastar Pharmaceuticals Shares Skyrocket, What You Need To Know

March 16, 2026

Via StockStory

NeoGenomics’ PanTracer LBx Receives Medicare Coverage, Expanding Access to Comprehensive Liquid Biopsy Profiling

March 16, 2026

From NeoGenomics, Inc.

Via Business Wire

NeoGenomics Inc (NASDAQ:NEO) Beats Q4 Earnings Estimates and Provides 2026 Guidance ↗

February 17, 2026

Via Chartmill

3 Reasons to Avoid NEO and 1 Stock to Buy Instead

February 25, 2026

Via StockStory

NeoGenomics Launches RaDaR ST, Expanding Molecular Residual Disease Testing Across Multiple Solid Tumor Types

February 25, 2026

From NeoGenomics, Inc.

Via Business Wire

5 Insightful Analyst Questions From NeoGenomics’s Q4 Earnings Call

February 24, 2026

Via StockStory

Why NeoGenomics (NEO) Shares Are Falling Today

February 18, 2026

Via StockStory

NeoGenomics to Participate in Upcoming Investor Conferences

February 18, 2026

From NeoGenomics, Inc.

Via Business Wire

NEO Q4 Deep Dive: Product Mix Shift and Guidance Weigh on Outlook

February 18, 2026

Via StockStory

NeoGenomics (NEO) Q4 2025 Earnings Call Transcript ↗

February 17, 2026

Via The Motley Fool

NeoGenomics’s (NASDAQ:NEO) Q4 CY2025 Sales Beat Estimates

February 17, 2026

Via StockStory

NeoGenomics Reports Fourth Quarter and Full Year 2025 Results

February 17, 2026

From NeoGenomics, Inc.

Via Business Wire

NeoGenomics (NEO) Q4 Earnings Report Preview: What To Look For

February 15, 2026

Via StockStory

NeoGenomics Introduces PanTracer Pro to Support Timely, Informed Solid Tumor Therapy Selection

February 12, 2026

From NeoGenomics, Inc.

Via Business Wire

1 Stock Under $50 Worth Your Attention and 2 We Brush Off

February 08, 2026

Via StockStory

NeoGenomics to Report Fourth Quarter and Full Year 2025 Financial Results on February 17, 2026

January 27, 2026

From NeoGenomics, Inc.

Via Business Wire

3 Cash-Burning Stocks with Warning Signs

January 18, 2026

Via StockStory

NeoGenomics Announces Preliminary Fourth Quarter and Full-Year 2025 Revenue

January 12, 2026

From NeoGenomics, Inc.

Via Business Wire

NeoGenomics to Participate in the 44th Annual J.P. Morgan Healthcare Conference

January 05, 2026

From NeoGenomics, Inc.

Via Business Wire

NeoGenomics Appoints Diagnostics and Lab Services Industry Veteran John P. “Jack” Kenny to its Board of Directors

December 30, 2025

From NeoGenomics, Inc.

Via Business Wire

3 Russell 2000 Stocks We Think Twice About

December 17, 2025

Via StockStory

3 Stocks Under $50 We Steer Clear Of

December 16, 2025

Via StockStory

NeoGenomics Announces that Natera Has Voluntarily Withdrawn its Appeal in Ongoing RaDaR Patent Litigation

December 15, 2025

From NeoGenomics, Inc.

Via Business Wire

Frequently Asked Questions

Is NeoGenomics, Inc. - Common Stock publicly traded?

Yes, NeoGenomics, Inc. - Common Stock is publicly traded.

What exchange does NeoGenomics, Inc. - Common Stock trade on?

NeoGenomics, Inc. - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for NeoGenomics, Inc. - Common Stock?

The ticker symbol for NeoGenomics, Inc. - Common Stock is NEO on the Nasdaq Stock Market

What is the current price of NeoGenomics, Inc. - Common Stock?

The current price of NeoGenomics, Inc. - Common Stock is 7.790

When was NeoGenomics, Inc. - Common Stock last traded?

The last trade of NeoGenomics, Inc. - Common Stock was at 04/02/26 11:05 AM ET

What is the market capitalization of NeoGenomics, Inc. - Common Stock?

The market capitalization of NeoGenomics, Inc. - Common Stock is 956.74M

How many shares of NeoGenomics, Inc. - Common Stock are outstanding?

NeoGenomics, Inc. - Common Stock has 957M shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.